Standout Papers
Citation Impact
Citing Papers
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
2016
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Imaging beyond the proteome
2012 StandoutNobel
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Magnesium basics
2012 Standout
Exercise Standards for Testing and Training
2013 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
A new definition of neuropathic pain
2011 Standout
Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey
2011
Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a “renal variant” phenotype1
2003
Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement
2006
The Role of X Inactivation and Cellular Mosaicism in Women's Health and Sex-Specific Diseases
2006
Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature
2018
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The microbiota of the respiratory tract: gatekeeper to respiratory health
2017
Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases
2012
Myocarditis
2011 Standout
Small fiber neuropathy in Fabry disease
2012
Neurological manifestations in Fabry's disease
2007
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data
2009
Interactions between the microbiota and pathogenic bacteria in the gut
2016 Nature
Microbiota Modulation of the Gut-Lung Axis in COVID-19
2021 Standout
Fabry disease: correlation between structural changes in α-galactosidase, and clinical and biochemical phenotypes
2005
High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*
2006 Standout
Myocarditis
2009 Standout
Monogenic Vessel Diseases Related to Ischemic Stroke: A Clinical Approach
2007
Magnesium in Man: Implications for Health and Disease
2014 Standout
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Introduction to the human gut microbiota
2017 Standout
MALDI-TOF and cluster-TOF-SIMS imaging of Fabry disease biomarkers
2006
Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping
2013
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Works of C. Kampmann being referenced
Composition of human faecal microbiota in resistance to Campylobacter infection
2015
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
2004 Standout
Anderson–Fabry disease: Clinical manifestations of disease in female heterozygotes
2001